Telemedicine, Health IT, Policy Senators pick two telehealth policy changes that should stay By Elise Reuter
BioPharma, Policy Senate committee panel puts drug industry CEOs on defensive over pricing By Alaric DeArment
MedCity Influencers, Devices & Diagnostics Five benefits to developing a global transparency policy By
Kaiser, Pharma The potential for conflict of interest when health policy experts also serve on the boards of pharma companies By Sarah Jane Tribble, Kaiser Health News
Kaiser Experts offered Senate HELP committee 9 proposals to cut drug prices. Here are the odds of passage By Sarah Jane Tribble, Kaiser Health News
Policy The friendly skies felled HHS Secretary Tom Price, so what’s next for healthcare policy? By Stephanie Baum
Daily FDA’s Patient Engagement Advisory Committee milestone reflects push for patient input on drug development By
